Literature DB >> 12100081

Ectopic growth hormone-releasing hormone secretion by thymic carcinoid tumour.

E Boix1, A Picó, R Pinedo, I Aranda, K Kovacs.   

Abstract

The case of a 33-year-old-woman with Multiple Endocrine Neoplasia Type 1 (MEN1) syndrome and acromegaly due to ectopic growth hormone-releasing hormone (GHRH) secretion by a thymic carcinoid tumour is reported. Immunohistochemistry revealed positive immunoreactivity for GHRH, vasoactive intestinal polypeptide, somatostatin and alpha-subunit in the tumour cells. A previously undescribed new germ line mutation of the MEN1 protein gene was revealed.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12100081     DOI： 10.1046/j.1365-2265.2002.01535.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


  10 in total

1.  Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.

Authors:  Patricia Fainstein Day; Lawrence Frohman; Hernan Garcia Rivello; Jean Claude Reubi; Gustavo Sevlever; Mariela Glerean; Tomas Fernandez Gianotti; Marcelo Pietrani; Alejandra Rabadan; Silvina Racioppi; Martin Bidlingmaier
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 2.  Acromegaly Caused by Ectopic Growth Hormone Releasing Hormone Secretion: A Review.

Authors:  Iga Zendran; Gabriela Gut; Marcin Kałużny; Katarzyna Zawadzka; Marek Bolanowski
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

3.  Ockham's Razor for a Retinal Lesion and Acromegaly and Breaking the Vicious Circle.

Authors:  Beata Rak-Makowska; Bernard Khoo; Piya Sen Gupta; P Nicholas Plowman; Ashley B Grossman; Márta Korbonits
Journal:  J Endocr Soc       Date:  2022-06-03

Review 4.  Endocrine neoplasms in familial syndromes of hyperparathyroidism.

Authors:  Yulong Li; William F Simonds
Journal:  Endocr Relat Cancer       Date:  2016-05-20       Impact factor: 5.678

5.  A non-acromegalic case of multiple endocrine neoplasia type 1 accompanied by a growth hormone-releasing hormone-producing pancreatic tumor.

Authors:  H Sugihara; T Shibasaki; A Tatsuguchi; F Okajima; S Wakita; Y Nakajima; K Tanimura; H Tamura; S Ishii; J Kamegai; H Akasu; W Kitagawa; K Shimizu; Y Nakamura; E Uchida; T Tajiri; Z Naito; H Katakami; S Oikawa
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

Review 6.  Ectopic acromegaly due to growth hormone releasing hormone.

Authors:  Ali A Ghazi; Alireza Amirbaigloo; Azizollah Abbasi Dezfooli; Navid Saadat; Siavash Ghazi; Marina Pourafkari; Farrokh Tirgari; Dheepti Dhall; Serguei Bannykh; Shlomo Melmed; Odelia Cooper
Journal:  Endocrine       Date:  2012-09-15       Impact factor: 3.633

7.  Clinical implication of MEN1 mutation in surgically resected thymic carcinoid patients.

Authors:  Xiongfei Li; Mingbiao Li; Tao Shi; Renwang Liu; Dian Ren; Fan Yang; Sen Wei; Gang Chen; Jun Chen; Song Xu
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

8.  Interpretation of the post-surgical Somatostatin Receptor Scintigram of a Primary Neuroendocrine Tumor of the Thymus: a case report and literature review.

Authors:  Anastasia Leondi; John Koutsikos; Cherry Zerva
Journal:  Int Semin Surg Oncol       Date:  2005-03-23

9.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

10.  Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients.

Authors:  Nienke R Biermasz; Jan W A Smit; Alberto M Pereira; Marijke Frölich; Johannes A Romijn; Ferdinand Roelfsema
Journal:  Pituitary       Date:  2007       Impact factor: 4.107
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.